F or efficient immunity, the different components of the immune system have to cooperate. The interplay among lymphokines, chemokines, and cellular and humoral immunity has been studied in numerous models of natural and targeted mutations (1) (2) (3) . However, collaboration between the innate and the adaptive immune system is not well explored because defects affecting the innate immune system, particularly macrophages or neutrophils, are often embryonically lethal or severely immunocompromise the host, leading to death soon after birth. Osteopetrotic (op) 4 mice carry a natural point mutation in the M-CSF gene (4 -7) and fail to develop marginal zone macrophages (MZM) in the spleen and the corresponding sinusoidal macrophages in the lymph nodes (8, 9) ; these mice are severely deficient in functional osteoclasts and therefore form inadequate bone marrow cavities. Despite these defects, op Ϫ/Ϫ mice develop normal in vivo phagocytic functions but have impaired release of TNF and G-CSF (10) . Although B cell lineage precursors are present in the bone marrow of these mice, B cell lymphopoiesis in adult op Ϫ/Ϫ mice is observed only in the liver (11) . Despite this, op Ϫ/Ϫ mice demonstrate normal B cell responses in vivo (10, 12) . Normal MLRs in vitro indicated that T cells from op Ϫ/Ϫ mice are functional (12) . It has been observed that macrophage depletion reduces the host capacity to control viral infections (13, 14) . Depletion of MZM can be experimentally induced by the administration of clodronate encapsulated in liposomes (15) (16) (17) . Using this experimental approach, it has been shown that such mice fail to control a systemic lymphocytic choriomeningitis virus (LCMV) infection (18) . However, long-term studies are difficult to carry out in MZM-depleted mice because the MZM are replenished and because repeated treatment with clodronate liposomes results in a high mortality rate with severe side effects resulting in noninterpretable results. Nevertheless, studies in MZM-depleted mice and in op Ϫ/Ϫ mice revealed that MZM play a role in controlling Listeria monocytogenes infections (19, 20) . Additionally, earlier studies had shown that LCMV-infected MZM were destroyed by virus-specific CTLs and caused systemic immunosuppression (21) . Non-or low-cytopathic viruses such as LCMV differ from cytopathic viruses such as vesicular stomatitis virus (VSV) in that the former are usually eliminated by CTLs, whereas neutralizing Abs induced during the course of the primary immune response usually control the latter. Common to both viruses is that they are initially recruited to lymphoid organs by natural Abs, where they are thought to be removed by MZM to reduce dissemination of virus to vital organs and at the same time enhance induction of an immune response (22) (23) (24) . The present study used op Ϫ/Ϫ mice to evaluate the contribution of MZM to the elimination of a non-or low-cytopathic virus vs a cytopathic virus and to investigate the effect of impaired removal of infectious virus on antiviral immunity and disease manifestation.
Materials and Methods

Mice and viruses
C57BL/6 mice were obtained from the breeding colony of the Institut für Labortierkunde (Faculty of Veterinary Medicine, University Zurich-Irchel, Zurich, Switzerland). Experiments were conducted with age-and sexmatched animals kept under specific pathogen-free conditions. Heterozygous op/ϩ mice were obtained from The Jackson Laboratory (Bar Harbor, ME), embryo-derived, back-crossed onto C57BL/6 for two generations, and kept under specific pathogen-free conditions according to institutional guidelines. Heterozygous breeding pairs were identified by PCR as previously described (5) . Inspecting them for the lack of incisors identified homozygous op Ϫ/Ϫ offspring. They were fed powdered mouse food and water supplemented with 5% glucose. Heterozygous and wild-type littermates were separated and sacrificed as early as possible from op Ϫ/Ϫ littermates to increase the survival rate of op Ϫ/Ϫ mice and to obtain a sufficient number of homozygotes. For this reason, i.e., lack of littermates, all experiments were conducted with age-matched (date of birth within the range of 2 wk) C57BL/6 control mice. Blood samples from experimental op Ϫ/Ϫ mice were checked for the presence of H-2 b by FACS analysis. Despite the possibility that inbred mouse strains may show altered kinetics of virus clearance, our longstanding experience with transgenic and knockout mouse lines generated on mixed genetic backgrounds showed that the immune responses against LCMV and VSV were identical to C57BL/6 after the first, and even more so the second, backcross to C57BL/6; thus, C57BL/6 were considered to serve as appropriate controls in our experiments.
VSV-IND (Mudd-Summers isolate) was originally obtained from D. Kolakofsky (University of Geneva, Geneva, Switzerland) and was grown on BHK cells in MEM with 5% FCS to virus stocks containing 10 9 PFU/ ml. LCMV-WE was originally provided by F. Lehmann-Grube (University Hamburg, Hamburg, Germany) and was grown on L-929 cells for 48 h in MEM with 5% FCS after infection with an initial multiplicity of infection of 0.01.
VSV neutralization assay
Mice were bled from the retroorbital cavity at the indicated time points. Serial 2-fold dilutions of serum samples (previously diluted 1/40) were mixed with equal volumes of VSV containing 500 PFU/ml and the mixtures were incubated for 90 min at 37°C in an atmosphere containing 5% CO 2 . A total of 100 l of the mixture was transferred onto Vero cell monolayers in 96-well plates and incubated for 1 h at 37°C. Monolayers were overlaid with 100 l of DMEM containing 1% methylcellulose and incubated for 24 h at 37°C, after which the overlay was removed and the monolayer was fixed and stained with 0.5% crystal violet dissolved in 5% formaldehyde, 50% ethanol, and 4.25% NaCl. The dilution reducing the number of plaques by 50% was taken as titer (25) . To determine IgG titers, undiluted serum was treated with an equal volume of 0.1 M 2-ME in MEM tissue culture medium for 1 h at room temperature.
Determination of VSV and LCMV titers in tissues
Mice were sacrificed by cervical dislocation. Brain tissue was homogenized in balanced salt solution, and serial 3-fold dilutions were plated on Vero cell monolayers in 96-well plates. Viral titers were calculated by multiplying counted plaques by the dilution factor. Mice without detectable virus in the brain (Ͻ10 3 PFU per brain) were scored negative (26, 27) . LCMV titers of organs of infected mice were determined in an infectious focus formation assay as described previously (28) . Briefly, spleen homogenates were serially diluted 10-fold and grown on an MC57G cell monolayer for 48 h under an overlay of 1% methylcellulose in DMEM. Cells were fixed with 4% formalin in PBS, and infectious foci were detected by intracellular LCMV staining of infected cells with the rat anti-LCMV mAb VL-4.
Cytotoxicity assay
The cytolytic activity of spleen cells was tested in a 51 Cr release assay as described previously (29) . Briefly, EL-4 target cells were coated with LCMV-derived peptide gp33-41 (30) at concentrations of 10 Ϫ6 M. A total of 10 4 target cells were incubated in 96-well round-bottom plates with serial 3-fold dilutions of spleen effector cells starting at an E:T ratio of 70:1 in a final volume of 200 l. After 5 h of incubation at 37°C, 70 l of supernatant was harvested and radioactivity determined in a gamma counter, and the percentage of specific release was calculated.
Secondary in vitro restimulation
A total of 5 ϫ 10 6 spleen cells and 2 ϫ 10 5 LCMV-infected peritoneal exudate macrophages were cocultured in 24-well tissue culture plates in a total volume of 2 ml IMDM supplemented with 10% FCS, penicillin/streptomycin, glutamine, and 5 ϫ 10 Ϫ5 M 2-ME. Macrophages were obtained by injecting mice i.p. with 1 ml thioglycolate on day Ϫ6 and with 200 PFU LCMV on day Ϫ4. After 5 days, 1 ml medium was removed and 100 l of these standard cultures were diluted in duplicate (four steps, 3-fold dilutions) in MEM supplemented with 2% FCS in 96-well round-bottom plates and specific cytotoxicity was determined as described above.
Immunohistochemistry
Freshly removed organs were immersed in HBSS and snap-frozen in liquid nitrogen. Tissue sections of 5-m thickness were cut in a cryostat, placed on siliconized glass slides, air dried, fixed with acetone for 10 min, and stored at Ϫ70°C. Second-stage affinity-purified polyclonal anti-Ig antisera were diluted in Tween-buffered saline (TwBS; pH 7.4) containing 5% normal mouse serum. All other dilutions were made in TwBS alone. Incubations were performed at room temperature for 30 min; TwBS was used for all washing steps. Alkaline phosphatase was visualized using naphthol AS-BI phosphate and New Fuchsin as substrate, which yields a red precipitate. Endogenous alkaline phosphatase was blocked by levamisole. All color reactions were performed at room temperature for 15 min with reagents from Sigma-Aldrich (St. Louis, MO). Sections were counterstained with hemalum. Coverslips were mounted with glycerol and gelatin. Stainings for the cell differentiation markers MOMA-1 (mouse metallophilic macrophages) and 4C11 (follicular dendritic cells (FDC)) were performed exactly as previously described (31) . The detection of VSV-Ag has been described previously (32) .
FIGURE 1. op
Ϫ/Ϫ mice fail to develop a footpad swelling reaction. op Ϫ/Ϫ (op) and C57BL/6 (B6) mice were injected into the hind footpad with 100 PFU LCMV and the footpad swelling reaction was monitored daily for the indicated time period. Each line represents one animal. Some mice were sacrificed for other experiments (discontinued lines). Data from two independent experiments are shown.
FIGURE 2. A, op
Ϫ/Ϫ mice develop strong but slightly reduced CTL responses. op Ϫ/Ϫ mice were injected i.f. with 100 PFU LCMV. CTL responses were measured in the spleen 9 days later on EL-4 target cells coated with LCMV peptide p33 (op if p33) or were left untreated (op if). C57BL/6 served as controls (B6 if p33 and B6 if, respectively). Data shown represent one of two independent experiments. B, op Ϫ/Ϫ mice fail to efficiently control LCMV during the acute phase. op Ϫ/Ϫ (op) and C57BL/6 (B6) control mice were injected into the footpad with 100 PFU LCMV and virus titers were measured in the indicated organs 9 days later.
Footpad swelling reaction
Mice were injected into the hind footpad with 100 PFU LCMV WE in 30 l of MEM supplemented with 2% FCS. The footpad thickness was measured with a spring-loaded caliper (Kroeplein; Schluchtern, Hessen, Germany). Values were taken as the mean of both hind footpads (29, 33) .
Results
op Ϫ/Ϫ mice fail to generate a primary footpad swelling reaction
To assess the capacity of op Ϫ/Ϫ mice to mount an immune response against non-or low-cytopathic LCMV, mice were infected via the footpad (i.f.) with LCMV. After footpad infection, immunocompetent mice develop a footpad swelling reaction due to a biphasic CD8 ϩ and CD4 ϩ T cell response (29, 33) . The strength and the kinetics of the swelling reaction correlate with the induction and recruitment of T cells to the site of infection. Naive mice show a strong swelling reaction on day 8 after infection, whereas LCMV-immune mice immediately clear the virus and therefore fail to generate a strong swelling reaction. To assess priming and homing of T cells in op Ϫ/Ϫ mice, 100 PFU LCMV WE were injected into the footpad of op Ϫ/Ϫ and C57BL/6 control mice (Fig.  1) . While C57BL/6 mice generated a strong swelling reaction on day 8, op Ϫ/Ϫ mice failed to produce a swelling reaction, suggesting that in op Ϫ/Ϫ mice LCMV either did not induce a T cell response or induced T cells did not migrate to the footpad. To evaluate whether op Ϫ/Ϫ mice generated LCMV-specific CTL responses measurable in vitro, cytotoxicity assays were performed with spleen cells from op Ϫ/Ϫ and C57BL/6 mice infected i.f. with LCMV ( Fig. 2A) . The data show that op Ϫ/Ϫ mice generated slightly reduced but still strong CTL responses. Thus, the lack of a footpad swelling reaction in op Ϫ/Ϫ mice cannot be explained by the lack of CTL induction but may rather reflect the failure of CTL homing to the footpad.
op
Ϫ/Ϫ mice are unable to control LCMV during the acute phase of the infection A possible explanation for the homing deficiency of CTL into the footpad is that virus spreads throughout all organs and recruits CTL away from the site of infection. To assess this possibility, virus titers in op Ϫ/Ϫ mice were determined in different organs of mice infected i.f. with 100 PFU LCMV (Fig. 2B) . LCMV titers were 10-to 50-fold increased in thymus, spleen, and liver of op Ϫ/Ϫ mice compared with C57BL/6 controls, suggesting that op Ϫ/Ϫ mice could not efficiently control virus spread during the acute phase. This observation was even more pronounced when 100 PFU LCMV were injected i.v., in which case virus titers in op Ϫ/Ϫ mice were 100 -10,000 times higher than in C57BL/6 controls: thymus op, 2.68 ϫ 10 6 Ϯ 9.1 ϫ 10 5 PFU; thymus B6, 1.1 ϫ 10 4 Ϯ 8.9 ϫ 10 3 PFU; liver op, 4.9 ϫ 10 7 Ϯ 2.6 ϫ 10 6 PFU; liver B6, 3.1 ϫ 10 3 Ϯ 2.9 ϫ 10 3 PFU; spleen op, 2.5 ϫ 10 7 Ϯ 2.2 ϫ 10 7 PFU; spleen B6, 1.2 ϫ 10 4 Ϯ 1 ϫ 10 4 PFU. Taken together, uncontrolled virus dissemination may lead to increased Ag loads in peripheral organs and deviation of CTL into these organs.
FIGURE 3. A, A proportion of op
Ϫ/Ϫ mice recovering from generalized immunopathology become virus carriers. Three groups of a total of 11 op Ϫ/Ϫ mice were injected i.f. with 100 PFU LCMV. Each group was tested in a separate experiment. The LCMV titers in the indicated organs were determined from eight surviving op Ϫ/Ϫ mice on days 21-28. Shown are the titers from six carrier op mice; two op mice cleared the virus as C57BL/6 control mice did. B and C, LCMV-specific CTL are recovered from virusfree op Ϫ/Ϫ mice (B) but not from carrier op Ϫ/Ϫ mice (C). Spleen cells from the surviving eight op Ϫ/Ϫ (op) from the groups described in A and the C57BL/6 control (B6) mice were restimulated in vitro with LCMV-infected macrophages. After 5 days the cultures were tested in the indicated serial dilutions for the presence of LCMV-specific CTL in 51 Cr release assays using EL-4 target cells coated with LCMV peptide p33 (op p33 and B6 p33) or untreated cells (op and B6). 
After LCMV infection op Ϫ/Ϫ mice developed a generalized immunopathology
Mice that cannot efficiently control virus spread show signs of generalized immunopathological disease. To evaluate whether op Ϫ/Ϫ mice eventually controlled LCMV infection, they were infected i.f. with LCMV and clinical symptoms of generalized immunopathology were monitored. In contrast to C57BL/6 mice, all LCMV-infected op Ϫ/Ϫ mice developed generalized immunopathology characterized by a hunched back, ruffled fur, and lethargy: 9 of 25 op Ϫ/Ϫ mice succumbed to the infection between days 12 and 18, and the remaining mice recovered completely from clinical symptoms by days 21-28. Thus, op Ϫ/Ϫ mice are immunocompromised and have difficulties controlling virus spread despite being able to generate significant primary CTL responses.
Impaired virus clearance in op Ϫ/Ϫ mice correlates with the lack of LCMV-specific CTL
To determine whether op Ϫ/Ϫ mice, which recover from transient immunopathology, eliminated the virus or became virus carriers due to CTL exhaustion (34 -36), a total of 11 op Ϫ/Ϫ mice were injected with LCMV into the footpad, virus titers were determined in the organs between days 21 and 28, and the presence of CTL was assessed in secondary in vitro assays. Three of the op Ϫ/Ϫ mice died with severe clinical symptoms of generalized immunopathology. Of the remaining eight op Ϫ/Ϫ mice, six mice failed to eliminate LCMV from all organs (Fig. 3A) and two mice completely cleared the virus below detectable levels (data not shown). After in vitro restimulation, LCMV-specific CTL could be recovered from the mice that had eliminated the viruses (Fig. 3B) , whereas no LCMV-specific CTL could be recovered from the carrier mice (Fig. 3C) . Thus, elimination of virus correlated with CTL activity, whereas impaired virus clearance correlated with the absence of LCMV-specific CTL.
op Ϫ/Ϫ mice mount normal B cell-neutralizing Ab responses to VSV but succumb to infection
To evaluate the potential of op Ϫ/Ϫ mice to control infection by a cytopathic virus, 2 ϫ 10 6 PFU VSV IND were injected i.v. and neutralizing Ab titers were monitored. Fig. 4A shows that op Ϫ/Ϫ mice mount normal neutralizing IgM and IgG Ab responses. However, surprisingly, mice succumb to lethal VSV infection between days 8 and 11 and VSV can readily be isolated from the brain of op Ϫ/Ϫ mice but not from control C57BL/6 mice (Fig. 4B, expt. 1 ). Early control of virus dissemination to avoid infection of vital organs by VSV is crucial for resistance to VSV infection (22, 37, 38) . To establish whether op Ϫ/Ϫ mice were able to control dissemination of VSV to the brain after infection with 100-fold lower doses of VSV, op Ϫ/Ϫ mice were infected i.v. with 2 ϫ 10 4 PFU of this virus (Fig. 4B, expt. 2) . The data show that op Ϫ/Ϫ mice infected with a low dose of VSV controlled the infection and did not succumb to VSV-mediated encephalitis.
VSV Ag is efficiently recruited to the spleen
Recruitment of VSV by natural Abs to secondary lymphoid organs plays a key role in controlling disease by reducing virus spread and enhancing induction of an immune response (22, 38) . op Ϫ/Ϫ mice lack metallophilic MZM in the spleen and subcapsular macrophages in the lymph nodes, and have normal FDC populations (Fig. 5, upper panels) . To investigate whether VSV was efficiently recruited to the spleen, op Ϫ/Ϫ mice were infected i.v. with 5 ϫ 10 8 PFU VSV. No difference in VSV titers was found in the spleens after 6 h of infection. Titers were Ͼ2.1 ϫ 10 8 PFU per gram of organ in both op Ϫ/Ϫ and control mice. Consistent with this, cryosections revealed that VSV Ag was recruited to the spleen. However, while VSV Ag was predominantly found in the marginal zone of C57BL/6 mice, VSV Ag could be found in the red pulp and the white pulp of op Ϫ/Ϫ mice. Moreover, the Ag largely colocalized with FDC in op Ϫ/Ϫ mice (Fig. 5) .
Discussion
For non-or low-cytopathic viruses the relative balance between virus spread and CTL response critically defines whether the virus will be cleared, immunopathology will ensue, or the immune response will be exhausted and the virus will persist (39) . Because cytopathic viruses directly destroy infected cells, they cannot establish a carrier state without killing the host; therefore, virus spread has to be controlled rapidly.
Early CTL and B cell responses against LCMV and VSV were largely unimpaired in op mice. The small reduction in the early day 8 cytotoxic activity of spleen cells against LCMV in op Ϫ/Ϫ mice is probably a consequence of virus dissemination and CTL extravasation into peripheral infected tissues rather than inefficient CTL priming. This view is consistent with the observation that op Ϫ/Ϫ mice failed to generate a footpad swelling reaction, probably due to CTL recruitment to many sites in addition to the infected footpad (40) .
All op Ϫ/Ϫ mice went through a critical phase of generalized immunopathology, which one-third of the mice did not survive. In a small proportion of the op Ϫ/Ϫ mice an efficient CTL response dominated over virus spread, virus was cleared, and LCMV-specific CTL could be recovered. However, most of the mice failed to completely clear LCMV from all organs (virus persisted particularly in the kidney) and no LCMV-specific CTL could be recovered, indicating that CTL had been exhausted.
It has previously been observed that T cell-dependent LCMV clearance involves cooperation between T cells and probably macrophages (14) . In addition, an earlier study by Seiler et al. (18) investigated the role of MZM in immunity against LCMV. The authors depleted MZM by administration of liposome-encapsulated clodronate (15) (16) (17) and reported that CTL responses were exhausted in all mice. There was no mention of generalized immunopathology, most likely because the treatment of mice with clodronate liposomes is stressful to the animal and clinical symptoms may have been masked due to this harsh treatment. In this work we show that three clinical outcomes are possible: 1) virus elimination accompanied by intact LCMV-specific CTL responses, 2) virus persistence and CTL exhaustion, or 3) death as a consequence of virus spread and immunopathological CTL response.
After infection with VSV, op Ϫ/Ϫ mice generated normal neutralizing (IgM plus IgG) and IgG responses; nevertheless, mice eventually succumbed to disease. Analysis of VSV titers in the brain revealed that virus spread could not be controlled in these mice and that VSV had disseminated to the brain. This was apparent with an infectious dose of 2 ϫ 10 6 PFU of VSV; however, a 100-fold lower dose was controlled. Natural Abs and complement have been implicated in directing Ag to lymphoid organs to accelerate and enhance immune responses (22, 38, 41) ; however, the precise mechanism by which virus spread is inhibited and influenced by MZM is unknown. VSV is sensitive to type I IFNs and thus early IFN responses generated by MZM may account for this inhibition. In op Ϫ/Ϫ mice, VSV Ag was recruited into the white pulp of the spleen and colocalized with FDC, while in C57BL/6 mice Ag localized to the marginal zone. Thus, Ag recruitment was still possible in op Ϫ/Ϫ mice, but to a different site. Additional experiments will be required to identify by which receptors VSV Ag is captured on FDC. Nevertheless, it seems clear that the Ag absorbance and removal capacity of the FDC are not sufficient to prevent viral dissemination.
op
Ϫ/Ϫ mice have been shown to generate normal MLR T cell responses and normal B cell responses in vivo against OVA (12) . The present study is consistent with these findings. However, despite generating normal T and B cell responses, op Ϫ/Ϫ mice were susceptible to viral infection. This points to the importance of the architecture of lymphoid organs for controlling viral infections in vivo (42) (43) (44) (45) . Crucial functions of structural components of lymphoid organs may not be uncovered if nonreplicating Ags are used. Although such experimental systems provide us with important information, they usually disclose rather a narrow window of the complex processes that are triggered by infections.
Taken together this study shows that the early innate immune system provides an important preparatory phase for the adaptive immune system: cooperation between the innate and the adaptive immune system shifts the balance between induction of an immune response and virus spread in favor of the immune response. This is particularly important for cytopathic viruses where virus spread usually leads to death, while non-or low-cytopathic viruses, depending on the relative balance between immune response and virus spread, can establish a virus carrier state without harming the host if extensive immunopathology is avoided.
